SPDR S&P Biotech ETF $XBI Shares Sold by PNC Financial Services Group Inc.

PNC Financial Services Group Inc. lowered its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 11.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 64,153 shares of the exchange traded fund’s stock after selling 8,542 shares during the quarter. PNC Financial Services Group Inc. owned 0.10% of SPDR S&P Biotech ETF worth $8,194,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Financial Life Planners purchased a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 4th quarter valued at approximately $27,000. Intesa Sanpaolo Wealth Management purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $30,000. SHP Wealth Management purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $31,000. Finally, Legacy Wealth Managment LLC ID purchased a new position in shares of SPDR S&P Biotech ETF during the 4th quarter valued at approximately $32,000.

SPDR S&P Biotech ETF Stock Performance

XBI stock opened at $150.48 on Monday. The firm has a 50 day simple moving average of $144.24 and a 200-day simple moving average of $133.53. The company has a market capitalization of $10.13 billion, a P/E ratio of 11.47 and a beta of 0.82. SPDR S&P Biotech ETF has a twelve month low of $84.39 and a twelve month high of $165.71.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.